The HIV+Hepatitis Policy Institute, a non-profit organization, is very grateful for support from individuals, foundations, and corporations that invest in our mission to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions. The HIV and Hepatitis Policy Institute is a 501(c)(3) tax-exempt organization. Donations to HIV+Hep are tax-deductible to the full extent allowed by law.
If you are interested in making a donation, please contact: Carl Schmid, Executive Director, at cschmid@hivhep.org.
1602B Belmont Street NW | Washington DC 20009
Facebook posts by @HIV+Hep
SCOTUS Appears Poised To Back USPSTF’s Role In Free Preventative Services: insidehealthpolicy.com/daily-news/scotus-appears-poised-back-uspstf-s-role-free-preventative-serv...
Eighty Advocacy Organizations Urge Labor Secretary to Close Harmful EHB Loophole--Will Curtail Drug Middlemen from Pocketing Copay Assistance: bit.ly/42V5eDN
MISTR’s free DoxyPEP program leads to 50% drop in STI positivity rate:
MISTR: DoxyPEP helps reduce STIs among patients by 50 percent
dallasvoice.com
In just 12 months, more than 74 percent of patients now request DoxyPEP bundled with their PrEP prescriptions, “highlighting massive demand for this underutilized prevention tool.”
MISTR's Free DoxyPep Leads to Huge Drop in STI Rates:
MISTR's Free DoxyPEP Leads to Huge Drop in STI Rates
www.metroweekly.com
The telehealth platform MISTR reports that its efforts to connect patients with DoxyPEP has led to a more than 50% drop in STI diagnoses.
New Jersey could lose HIV funding:
New Jersey could lose HIV funding
outinjersey.net
Recently, the Wall Street Journal reported that the Trump administration is considering eliminating all CDC domestic HIV funding or transferring its programs to another federal agency. Carl Schmid,...